New Key Statistics Module, Z-Score and F-Score
NYSE:GSK Key Ratios
Market Cap $ M | 69,430.05 |
Enterprise Value $ M | 84,840.92 |
P/E(ttm) | 21.96 |
PE Ratio without NRI | 18.68 |
Forward PE Ratio | 8.21 |
Price/Book | 3.90 |
Price/Sales | 1.76 |
Price/Free Cash Flow | 11.53 |
Price/Owner Earnings | 12.66 |
Payout Ratio % | 0.84 |
Revenue (TTM) $ M | 40,176.00 |
EPS (TTM) $ | 1.55 |
Beneish M-Score | -3.01 |
10-y EBITDA Growth Rate % | 1.10 |
5-y EBITDA Growth Rate % | 1.00 |
y-y EBITDA Growth Rate % | -31.80 |
EV-to-EBIT | 16.98 |
EV-to-EBITDA | 9.98 |
PEG | 18.68 |
Shares Outstanding M | 2,040.26 |
Net Margin (%) | 8.02 |
Operating Margin % | 14.37 |
Pre-tax Margin (%) | 10.52 |
Quick Ratio | 0.53 |
Current Ratio | 0.81 |
ROA % (ttm) | 4.26 |
ROE % (ttm) | 18.28 |
ROIC % (ttm) | 8.01 |
Dividend Yield % | 4.60 |
Altman Z-Score | 1.61 |
GSK Number of Guru Trades
GSK Volume of Guru Trades
Gurus Latest Trades with NYSE:GSK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:GSK is held by these investors
Total 6
GSK PLC Insider Transactions
No Available Data
News about NYSE:GSK
Total 0- 1